
Therapeutic Segment
Anticoagulant
CAS No.
503612-47-3
Regulatory Filing
USDMF, E-DMF
Development Status
DMF Filed
Molecule Type
Small Molecule
Mechanism of Action
Apixaban is a selective inhibitor of Fxa. By inhibiting FXa, apixaban decreases thrombin generation and thrombus development.